Brief: Northwest Biotherapeutics extends exercise period of series B warrants
03/05/2016 14:07
May 3 (Reuters) - Northwest Biotherapeutics Inc NWBO.O :
* On may 2, co and holders of co's series B warrants agreed
to extend exercise period of series b warrants from may 2, 2016
to may 23, 2016
Source text for Eikon: urn:newsml:reuters.com:*:nEOL2h16Nc
Further company coverage: NWBO.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB